Tradestie Institutional Equity Comparison Engine
PFSA vs LABT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PFSA Overall Edge
PFSA Captures Institutional Edge (2โ0 Pillars ยท 7โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Profusa, Inc. Common Stock (PFSA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, PFSA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus LABT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PFSA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LABT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PFSA N/M vs LABT N/M Fwd P/E
Growth & Margin Winner
PFSA
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
PFSA
1Y +91.4% vs -97.2% ยท 52W Pos 1% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PFSA
NASDAQ
Profusa, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.32
-6.4% 1D
Market Cap
$2.0M
1M Return
-68.29%
1Y Return
+91.36%
Forward P/E
N/M
Unified AI Score
48.7 / 100
HOLD
Tech 45.0
Fund 50.0
Flow 50.0
Mom 64.0
LABT
US Equity
LABT
Institutional Equity
$0.24
+15.03% 1D
Market Cap
N/A
1M Return
-49.97%
1Y Return
-97.17%
Forward P/E
N/M
Unified AI Score
47.5 / 100
HOLD
Tech 45.0
Fund 48.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PFSA +91.36%
LABT -97.17%
Spread: +51.47 pp (PFSA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PFSA TTM Op. Margin: 0.0%
LABT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PFSA vs LABT. Trailing 12-month operating profitability (PFSA 0.0% vs LABT N/A) and valuation multiples (PFSA N/M vs LABT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PFSA | LABT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.0M | N/A | Larger Scale | PFSA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | PFSA |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | PFSA |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | PFSA |
| Return on Equity (ROE) Capital Efficiency | 0.0% | N/A | Higher ROE | PFSA |
| 52-Week Range Position Momentum | 1% ($0โ$28) | 1% ($0โ$10) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | -9.00ฮฒ ยท 92% Vol | -8.45ฮฒ ยท 672% Vol | Lower Realized Risk | PFSA |
| Unified Institutional Score Composite Signal | 48.7 / 100 (HOLD) | 47.5 / 100 (HOLD) | Higher Composite | PFSA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PFSA vs LABT Buy Guide
PFSA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
LABT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PFSA nor LABT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.